Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®



Status:Completed
Conditions:Orthopedic
Therapuetic Areas:Orthopedics / Podiatry
Healthy:No
Age Range:50 - Any
Updated:1/3/2018
Start Date:December 2006
End Date:June 2010

Use our guide to learn which trials are right for you!

Long-term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts

The Long-Term Outcomes Study (LTOS) is a multi-center longitudinal cohort study of all
patients who received the X-STOP device in the Pivotal Trial, Continued Access Protocol
(CAP), or Cross-over Study (COS). It is designed to supplement postmarket safety and
effectiveness data to be gathered in a Condition of Approval (CoA) study of a population of
patients with moderately impaired physical function who elect to undergo X-STOP surgery.

Evaluate the long term safety and effectiveness of the X-Stop interspinous process
decompression system In the patients who received the X-Stop under the IDE. These patients
consist of two cohorts to be evaluated: patients who had moderately impaired physical
function prior to X-Stop implantation (as determined by a baseline score >2.0 in the physical
function (PF) domain of the Zurich claudication questionnaire), and patients who had mildly
impaired physical function prior to X-Stop surgery(as determined by a baseline score <=2.0 in
the PF domain of the Zurich claudication questionnaire (ZCQ), through the fifth postoperative
year. Clinical examination will be performed at each office visit to confirm the absence of
neurological complications. X-ray films (AP/lateral views) taken during the fifth
postoperative year will, be analyzed to confirm A) maintenance of distraction and B) the
absence of radiological evidence of device-related complications. Secondary endpoints will
include mean scores from the SF-36, and incidence rates of adverse events, device failures,
and secondary surgeries.

Inclusion Criteria:

A patient will be admitted into the LTOS program if he/she meets all of the following
inclusion criteria:

1. Completed participation in the Pivotal Trial, CAP, or COS and has the X STOP
implant(s) intact at the time of LTOS enrollment; OR is an active CAP/COS participant,
has the X STOP implant(s) intact, and has not completed a 24-month follow-up visit in
his/her CAP/COS study.

2. Is willing and able to provide Informed Consent

3. Is willing and able to return to the clinic for a clinical evaluation or complete
study questionnaires without a clinic visit.

Exclusion Criteria:

A patient will not be admitted into the LTOS program if he/she meets any of the following
exclusion criteria:

1. Participated in the Pivotal Trial as part of the X STOP group, but the device has been
removed.

2. Participated in the CAP or COS programs, but the device has been removed.
We found this trial at
5
sites
600 Highland Avenue
Madison, Wisconsin 53792
1615
mi
from 98109
Madison, WI
Click here to add this to my saved trials
301 Riverview Avenue
Norfolk, Virginia 23510
2429
mi
from 98109
Norfolk, VA
Click here to add this to my saved trials
San Francisco, California 94117
680
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
49 Spring Street
Scarborough, Maine 04074
2479
mi
from 98109
Scarborough, ME
Click here to add this to my saved trials
Timonium, Maryland 21093
2323
mi
from 98109
Timonium, MD
Click here to add this to my saved trials